Abionyx Pharma SA
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Abionyx Pharma SA
Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.
/ 
Others were interested in
Frequently asked questions
To buy Abionyx Pharma SA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Abionyx Pharma SA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Abionyx Pharma SA is ABNX:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Abionyx Pharma SA has its primary listing on Euronext Paris. You can trade Abionyx Pharma SA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Abionyx Pharma SA is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Abionyx Pharma SA as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Abionyx Pharma SA.